Akums Drugs and Pharmaceuticals Ltd Launches Dual Action Heartburn Relief Chewable Tablet

Akums Drugs & Pharmaceuticals Limited ("the Company") is pleased to announce the launch of its new product Famotidine, Calcium Carbonate and Magnesium Hydroxide in the Indian market.

This product is categorized as Antacids, Antiflatulents and Anti-Ulcerants and this product will cater to the Indian domestic market.

This product launch marks a step in commitment to innovation and providing high-quality healthcare solutions to our customers. We believe that new products will enhance our product portfolio and contribute positively to the Company's growth trajectory.

Shares of Akums Drugs and Pharmaceuticals Limited was last trading in BSE at Rs. 852.50 as compared to the previous close of Rs. 841.95. The total number of shares traded during the day was 7742 in over 817 trades.

The stock hit an intraday high of Rs. 861.00 and intraday low of 849.05. The net turnover during the day was Rs. 6625523.00.

Source : Equity Bulls

Keywords

AkumsDrugsandPharmaceuticals AKUMS INE09XN01023 NewProductLaunch Famotidine CalciumCarbonate MagnesiumHydroxide